For now, 351(k) filers can opt out of the patent dance with essentially no penalty. However, this may change when the US Supreme Court hears the Amgen-v-Sandoz case (#msg-120581818) in about two months (#msg-127876293).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”